drugset
drugset / Trial / NCT00957346

Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14-21 Weeks LMP)

NCT00957346 ↗

Phase 3 Terminated 20 enrolled Gynuity Health Projects University of Puerto Rico · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

The primary goal of this study is to determine the clinical advantage of pre-treatment with mifepristone in second trimester misoprostol induction abortion. This will be a randomized controlled double-blinded trial of 20 women comparing misoprostol alone to mifepristone plus misoprostol for second trimester (14-21 weeks' LMP) medical abortion.

Timeline

Start
2011-02
Primary completion
2012-01
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Mifepristone Small molecule 200 mg —
Background Misoprostol Other / unclassified 400 ug Other

Indications

No indication recorded.